Back to Search Start Over

Reclassifying severity after 48 hours could better predict mortality in acute respiratory distress syndrome

Authors :
Chen-Yiu Hung
Pi-Hua Liu
Chung-Shu Lee
Han-Chung Hu
Shih-Hong Li
Huang-Pin Wu
Li-Chung Chiu
Li-Pang Chuang
Hsin-Hsien Li
Chung-Chi Huang
Shih-Wei Lin
Kuo-Chin Kao
Chih-Hao Chang
Source :
Therapeutic Advances in Respiratory Disease, Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Publication Year :
2020
Publisher :
SAGE Publications, 2020.

Abstract

Background: Disease severity may change in the first week after acute respiratory distress syndrome (ARDS) onset. The aim of this study was to evaluate whether the reclassification of disease severity after 48 h (i.e. day 3) of ARDS onset could help in predicting mortality and determine factors associated with ARDS persistence and mortality. Methods: We performed a secondary analysis of a 3-year prospective, observational cohort study of ARDS in a tertiary care referral center. Disease severity was reclassified after 48 h of enrollment, and cases that still fulfilled the Berlin criteria were regarded as nonresolving ARDS. Results: A total of 1034 ARDS patients were analyzed. Overall hospital mortality was 57.7% (56.7%, 57.5%, and 58.6% for patients with initial mild, moderate, and severe ARDS, respectively, p = 0.189). On day 3 reclassification, the hospital mortality rates were as follows: resolved (42.1%), mild (47.9%), moderate (62.4%), and severe ARDS (76.1%) ( p 2/FiO2, or higher positive end-expiratory pressure on day 1 were significantly associated with nonresolving ARDS on day 3. A Cox regression model with ARDS severity as a time-dependent covariate and competing risk analysis demonstrated that ARDS severity was independently associated with hospital mortality, and nonresolving ARDS had significantly increased hazard of death than resolved ARDS ( p Conclusions: Reclassification of disease severity after 48 h of ARDS onset could help to divide patients into subgroups with greater separation in terms of mortality. The reviews of this paper are available via the supplemental material section.

Details

ISSN :
17534666
Volume :
14
Database :
OpenAIRE
Journal :
Therapeutic Advances in Respiratory Disease
Accession number :
edsair.doi.dedup.....169215126436fc867308fd388bb42a6b
Full Text :
https://doi.org/10.1177/1753466620936877